Author: >Pasquale De Bellis,

Source: Drugs, Volume 69, Supplement 1, 2 November 2009 , pp. 99-102(4)

Publisher: Adis International

Abstract:

Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections. Anidulafungin is a well tolerated echinocandin with a favorable pharmacokinetic profile; in particular, its lack of hepatic metabolism and renal excretion enables drug administration without dosage adjustment to subjects with any degree of impaired hepatic or renal function. This simplifies dosing, with a requirement for only once-daily administration and a lack of drug-drug interactions in patients who require multiple medications.

Document Type: Research article

Affiliations: 1: UOC Institute of Anesthesia and Resuscitation, Department of Cardiac-Nephrology, Azienda Ospedaliera Universitaria S. Martino di Genova, Genoa, Italy

Publication date: 2009-11-02

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology ,  Therapeutics & Alternative Medicine
• By this author: >Pasquale De Bellis,

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers